Legal & Regulatory Affairs
Copaxone & Multiple Sclerosis
Product Approvals & Launches (Generic & Branded)
Azilect & Parkinson Disease
For all global news, visit our
Teva to Host Conference Call to Discuss Fourth Quarter and Full Year 2018 Financial Results at 8 a.m. ET on February 13, 2019
JERUSALEM--(BUSINESS WIRE)--Jan. 14, 2019-- Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that it will issue a pr...
Teva to Present at the 37th Annual J.P. Morgan Healthcare Conference
JERUSALEM--(BUSINESS WIRE)--Jan. 6, 2019-- Teva Pharmaceutical Industries (NYSE and TASE: TEVA) today announced that members of manageme...
Teva and Amgen Resolve Ongoing Dispute Over Teva’s Generic Cinacalet HCl Product
PARSIPPANY, N.J.--(BUSINESS WIRE)--Jan. 2, 2019-- Teva Pharmaceutical Industries Ltd., (NYSE and TASE: TEVA) announced today that it has...